SCHEMBL8551129

SCHEMBL8551129

CCCOc1ccc2[nH]cc(C(=O)C(=O)N(C)C)c2c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.63
HTR1A P08908 8/20 0.51
HTR1B P28222 8/20 0.51
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
CYP1A2 P05177 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP2C19 P33261 2/20 0.48
ALDH1A1 P00352 1/20 0.48
MAPT P10636 2/20 0.47
MITF O75030 1/20 0.47
LMNA P02545 1/20 0.47
RAB9A P51151 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
HTR1D P28221 7/20 0.46
NR4A2 P43354 1/20 0.46
KDM4E B2RXH2 2/20 0.43
CPT1A P50416 1/20 0.43
TP53 P04637 1/20 0.43
CYP3A4 P08684 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31579432 0.85 HTT (0.49) HTTHTR1AHTR1BMEN1KMT2A
SCHEMBL8549655 0.85 HTT (0.66) HTTHTR1AHTR1BMEN1KMT2A
SCHEMBL24906138 0.83 NR4A2 (0.66) MEN1KMT2ACYP1A2CYP2C9CYP2C19
SCHEMBL7448403 0.82 HTR1D (0.57) MEN1KMT2AALDH1A1MAPTHTR1D
SCHEMBL31377509 0.80 NR4A2 (0.54) MEN1KMT2ACYP1A2CYP2C9CYP2C19
SCHEMBL29989077 0.79 NR4A2 (0.50) HTR1AMEN1KMT2ACYP1A2CYP2C9
SCHEMBL12721389 0.76 MAPT (0.71) HTTHTR1AHTR1BMEN1KMT2A
SCHEMBL5176370 0.75 HPGD (0.46) CYP2C19ALDH1A1LMNARAB9ANR4A2
SCHEMBL30622613 0.75 KDM4E (0.55) KMT2AALDH1A1KDM4EHTR2AMTNR1A
SCHEMBL24243764 0.75 KDM4E (0.55) KMT2AALDH1A1KDM4EHTR2AMTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0593513-B1 TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE RECEPTORS OR 5-HT2 RECEPTOR AGONISTES SMITHKLINE BEECHAM PLC (GB) 1998-10-28 EP disclosed
US-5571833-A TREATMENT OF MIGRAINE, PORTAL HYPERTENSION SMITHKLINE BEECHAM PLC (GB) 1996-11-05 US disclosed